PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Sanofi to buy Kiadis

Sanofi has entered into a deal to buy Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicin...
Continue Reading →
News

Lilly, Incyte tout new baricitinib data in eczema

Eli Lilly and Incyte showcased new data for their JAK inhibitor baricitinib in eczema at the virtual European Academy of Dermatology and Venereology (EADV) congress ...
Continue Reading →
News

EMA begins evaluation of filgotinib for ulcerative colitis

Gilead and Galapagos’ application seeking approval for their oral JAK1 inhibitor filgotinib as a treatment for ulcerative colitis has been validated by the European ...
Continue Reading →
News

ACG ACQUIRIES SIGNIFICANT STAKE IN MUMBAI-BASED IQGEN-X

The investment is aimed at augmenting R&D and IP in drug development.The funds infusion will enable IQGEN-X to fast-track research on existing ANDAs and also set...
Continue Reading →
News

ACG ACQUIRIES SIGNIFICANT STAKE IN MUMBAI-BASED IQGEN-X

The investment is aimed at augmenting R&D and IP in drug development.The funds infusion will enable IQGEN-X to fast-track research on existing ANDAs and also set...
Continue Reading →
News

Parkinson’s UK partners with UCL on phase II trial

Parkinson’s UK has partnered with University College London (UCL) and will invest £1m in a phase II clinical trial to investigate if the drug ondansetron can allevia...
Continue Reading →
News

Bayer’s Nubeqa wins NICE prostate cancer backing

Bayer’s Nubeqa has scored backing from the UK’s National Institute for Health and Care Excellence (NICE) for treating non-metastatic castration-resistant prostate ca...
Continue Reading →
News

Novartis’ rare renal disease candidate shows promise in phase II

Interim analysis results for Novartis’ rare renal disease candidate iptacopan proved promising in a phase II study of the investigational drug. The oral investigat...
Continue Reading →
News

AZ presents new real-world chronic kidney disease data at ASN 2020

AstraZeneca presented new findings from the DISCOVER Chronic Kidney Disease (CKD) study at the American Society of Nephrologists (ASN) Kidney Week 2020 Congress last...
Continue Reading →
News

Enhertu bags US priority review for HER2 gastric cancer

AstraZeneca’s Enhertu has scored a priority review from the US Food and Drug Administration (FDA) for the treatment of HER2-positive metastatic gastric cancer. Dai...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026